Submission Of The Canadian Association Of Medical Cannabis Dispensaries To The BC Cannabis Legalization And Regulation Secretariat November 1, 2017 A “Made In BC” Solution for Cannabis Regulation Established in 2010, the Canadian Association of Medical Dispensaries (CAMCD), is a non-profit, trade organization representing over 60 medical cannabis dispensaries in Canada. Member dispensaries provide […]
The Canadian Association of Medical Cannabis Dispensaries issued its official response to the Standing Committee on Public Health regarding Bill C-45 also known as “the Cannabis Act”.
While there are many issues to discuss with government regarding the Cannabis Act, CAMCD felt that the priority must be to ensure that storefront dispensaries are included in the new regulated regime to ensure no adverse impact to public health (continuity of access) and to the thousands of jobs currently maintained within the cannabis economy. Without inclusion in the new regulated environment there CAMCD feels there is no point in addressing other subjects related to distribution.
Lobbying by special interest groups intended to discredit dispensary services and ban them from the future regulated cannabis distribution economy has been ongoing for some time now. CAMCD hopes that submissions like these can help educate lawmakers and public policy groups and provide them with an evidence based approach to why existing dispensaries should have a place in the new regulatory framework.
Blocked from the federal medical marijuana testing system, dispensaries are creating their own
VANCOUVER— The Canadian Association of Medical Cannabis Dispensaries (CAMCD) is moving to set up testing standards and protocols to ensure the safety of the cannabis member dispensaries are selling.
Association President Jeremy Jacob says, “We believe consumers should be empowered to make educated choices about the cannabis products they buy, so we are moving to set up a rigorous, independent and transparent cannabis testing system.”
CAMCD promotes a regulated community-based approach to cannabis access with member dispensaries across Canada serving over 150,000 consumers.
Store front cannabis dispensaries are not allowed to test their product through federally licensed laboratories. Jacob says CAMCD is setting up its own testing standards after federally licensed medical marijuana producers recalled cannabis contaminated with the chemicals bifenazate and myclobutanil in November and December 2016, and were slow to inform the public.
“Dispensary clients need to know the product is free of contaminants. Consumers should be able to see testing results,” says Jacob. “Some of our member dispensaries are already testing their product privately, but we need a system where all are able to test their product, the labs are independent, and the consumer can rely on the results.”
The CAMCD board has created a working group with dispensary owners, cannabis producers, processors, and lab owners, to create guidelines and structure for the testing program. The board wants the system to be in place by May 2017.
Association President Jeremy Jacob will be available for questions today at 4:30 PST
Jeremy Jacob (604) 317-5759
Vancouver—The Canadian Association of Medical Cannabis Dispensaries (CAMCD) condemns the violent attack on two employees of the Medicinal Cannabis Dispensary (MCD) at 880 East Hastings on Friday. Our first concern is for the health of the employees and we wish them a speedy and full recovery from their injuries. This attack was cruel and disturbing for any community.
There is a $10,000 reward being offered by the Medicinal Cannabis Dispensary for the conviction of the perpetrators of this crime. If you have any information MCD is asking you reference VPD file 17 34969.
CAMCD thanks the Vancouver Police Department for their fast response and attention to this matter. Their care for all members of the community sets an example that other Canadian police forces should aspire to.
200 – 225 West 8th Ave.